| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,371 |
2,172 |
$112K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,305 |
2,097 |
$78K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
558 |
545 |
$42K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
542 |
516 |
$41K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,321 |
1,008 |
$31K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
296 |
283 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
753 |
731 |
$9K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,124 |
895 |
$9K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
104 |
100 |
$9K |
| 96373 |
|
496 |
467 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
478 |
237 |
$6K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
60 |
59 |
$2K |
| 87807 |
|
198 |
191 |
$2K |
| 87276 |
|
95 |
90 |
$990.63 |
| 87275 |
|
93 |
90 |
$755.09 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
425 |
396 |
$529.31 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
31 |
28 |
$372.06 |
| 96160 |
|
159 |
152 |
$310.50 |
| 90461 |
|
861 |
724 |
$179.26 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
17 |
13 |
$1.52 |
| 90677 |
|
177 |
176 |
$0.46 |
| 90697 |
|
83 |
83 |
$0.25 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
152 |
143 |
$0.11 |
| 90671 |
|
19 |
19 |
$0.06 |
| 90656 |
|
15 |
15 |
$0.00 |
| 90723 |
|
40 |
35 |
$0.00 |
| 90686 |
|
68 |
67 |
$0.00 |
| 90670 |
|
73 |
68 |
$0.00 |
| 90633 |
|
69 |
62 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,731 |
1,610 |
$0.00 |
| 90681 |
|
55 |
51 |
$0.00 |
| 90648 |
|
76 |
71 |
$0.00 |